Bringing specialized expertise and innovative research to complex pulmonary vascular disease
Pulmonary vascular disease is a rapidly evolving field, with emerging therapies, new diagnostic approaches and ongoing research reshaping how patients with pulmonary hypertension are evaluated and treated.

At the Temple Lung Center, pulmonary vascular disease expertise is paired with an active clinical research program focused on advancing care for patients with complex disease. Through participation in clinical studies and collaboration with investigators and research partners, the program provides opportunities to evaluate emerging approaches across pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Active Research in Pulmonary Vascular Disease
Current research opportunities include studies evaluating emerging therapeutic approaches as well as novel approaches to identifying pulmonary hypertension and PAH.

Research areas include:

• Pulmonary Arterial Hypertension (PAH)
  Clinical research involving patients with established WHO Group 1 PAH, including patients receiving existing PAH-directed therapies.
• PH Associated With Interstitial Lung Disease (PH-ILD)
  Studies evaluating patients with WHO Group 3 ILD-PH and defined pulmonary function, imaging and hemodynamic characteristics.
• Emerging Therapies
  Clinical studies evaluating new approaches to the treatment of pulmonary vascular disease, including therapies involving established and emerging treatment pathways.
• Innovative Diagnostics and Technology
  Research exploring novel approaches to identifying pulmonary hypertension and PAH, including the use of artificial intelligence.

Click here to download the quick-reference guide of active PAH and PH-ILD studies.

A Seamless Referral Experience
For pulmonologists caring for patients whose disease is progressive, complex or difficult to manage, Temple offers access to specialized pulmonary vascular expertise and actively enrolling research opportunities. Our multidisciplinary approach and active collaboration with radiology, rheumatology, hematology, genetic testing, and cardiology specialists ensure patients receive appropriate treatment and personalized care ranging from medical management, access to breakthrough clinical trials, and transplant for advanced or end-stage lung disease.

The Temple Lung Center partners closely with referring physicians to streamline evaluation and treatment.

Our team:

• Reviews each patient comprehensively to determine trial eligibility or alternative treatment options
• Coordinates all aspects of care and intervention
• Maintains clear and consistent communication with referring providers

Now Enrolling Patients
For more information on currently enrolling clinical trials at the Temple Lung Center, click here.

To refer a patient to the PVD program or for a clinical trial, click here.